Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling

Clinical Cancer Research

Volumn 7, Issue 4, 2001, Pages 918-927

  Currie, Margaret J ^a   Gunningham, Sarah P ^a   Han, Cheng ^b   Scott, Prudence A E ^a   Robinson, Bridget A ^a   Harris, Adrian L ^b   Fox, Stephen B ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; LIGAND; MESSENGER RNA; PROTEIN TYROSINE KINASE; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; VASCULARIZATION;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANGIOPOIETINS; BREAST NEOPLASMS; ESTROGENS; FEMALE; GENE EXPRESSION; GROWTH SUBSTANCES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTOR, TIE-2; RNA, MESSENGER; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED;

EID: 0034896568     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. What is the evidence that tumors are angiogenesis dependent
2. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?
3. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?
4. Expression of tie receptor tyrosine kinase in leukemia cell lines
5. The Tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells
6. Vascularization of the mouse embryo: A study of flk-1, tek, tie, and vascular endothelial growth factor expression during development
7. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage
8. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system
9. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells
10. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
11. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
12. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
13. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
14. Chemotactic properties of angiopoietin-1 and-2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
15. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
16. Angiopoietin-1 is an apoptosis survival factor for endothelial cells
17. Angiopoietin-1 induces sprouting angiogenesis in vitro
18. GRB2 and SH-PTP2: Potentially important endothelial signalling molecules downstream of the TEK/TIE2 receptor tyrosine kinase
19. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt
20. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: Mutant Tie-2 causing venous malformations signals a distinct STAT activation response
21. Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells
22. Identification of Tek/Tie2 binding partners: Binding to a multifunctional docking site mediates cell survival and migration
23. Identification of a family of alternatively spliced mRNA species of angiopoietin-1
24. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
25. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
26. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family
27. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
28. Analysis of blood vessel maturation es during cyclic ovarian angiogenesis
29. Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: A receptor ligand model for vascular remodelling
30. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
31. Blood vessel formation: What is its molecular basis?
32. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer
33. Correlation of intratumoral endothelial-cell proliferation with microvessel density (tumor angiogenesis) and tumor-cell proliferation in breast-carcinoma
34. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: Correlation with p53 and angiogenic factor expression
35. Grading of invasive carcinoma of the breast
36. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
37. Effect of estradiol on human breast cancer cells in culture
38. Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens
39. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study
40. Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1
41. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
42. Tumor angiogenesis in node-negative breast carcinomas: Relationship with epidermal growth factor receptor, estrogen receptor, and survival
43. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients
44. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer
45. Relationship of elevated tumour thymidine phosphorylase in node positive breast carcinomas to the effects of adjuvant CMF
46. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium
47. The distribution of LH39 basement membrane epitope in the tumour stroma of oral squamous cell carcinomas
48. A novel lamina lucida component of epithelial and endothelial basement membranes detected by LH39 monoclonal antibody
49. Vascular remodeling in breast cancer angiogenesis assessed by LH39 basement membrane antigen and CD31
50. Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39
51. Thymidine phosphorylase is angiogenic and promotes tumor growth
52. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
53. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer
54. Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer
55. Expression and function of angiopoietin-1 in breast cancer
56. Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis
57. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
58. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis
59. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
60. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
61. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor
62. Vascular endothelial growth factor and the angiopoietins: Working together to build a better blood vessel
63. Oestrogen and endothelial cell angiogenic activity
64. Efects of 17β-estradiol on cytokine induced endothelial cell adhesion molecule expression
65. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model
66. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth
67. 2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and β-galactosidase expression in vascular endothelial cells
68. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
69. Two independent mechanisms essential for tumor angiogenesis: Inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway